5 data-"https:" "https:" "https:" "https:" "https:" "https:" "https:" "Dr" "FEUP" positions at Center for Biologics Evaluation and Research (CBER)

FDA Computational and Experimental Assessment of Engineered Biotherapeutics: Safety and Regulatory Considerations of Synonymous Gene Recoding

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 2 days ago

Biol, 169718 (2026). https://doi.org:10.1016/j.jmb.2026.169718 Katneni, U.K., Liss, A., Holcomb, D., Katagiri, N., Hunt, R.C., Bar, H., Ismail, A., Komar, A.A. and Kimchi-Sarfaty, C.: Splicing

FDA Optimization Modeling to Support Benefit-Risk Assessment Fellowship

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 2 days ago

, which could include Bayesian methodologies and use of artificial intelligence to systematically integrate available information for evolving benefit-risk assessment. The goal is to tackle the major

FDA Non-clinical Identification and Mitigation of Safety Risks During the Development and Licensure of Protein-therapeutics

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 2 days ago

the Guidelines for Non-U.S. Citizens Details page  of the program website for information about the valid immigration statuses that are acceptable for program participation. This program, administered by ORAU

FDA Prophylactic Vaccine Against Visceral Leishmaniasis

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 2 days ago

information.

FDA Evaluation and Characterization of Neutralizing Antibodies Against Viruses Relevant to Blood-Derived Products

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 2 days ago

of the FDA; ORISE fellow’s obligation to protect and not to further disclose or use non-public information.